COMP <GO>
CTKB vs JNJ // 10Y YIELD & FRED MACRO BETA
Cytek Biosciences Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: CTKB 1
— JNJ 9
■ METRIC PARITY
LAST: $6.30 (+2.61%) • MKT CAP: $818.9M
macro-sensitivity
—
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
macro-sensitivity
1.08
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CTKB VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CTKB | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 51.80% | 67.90% | -16.10 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -12.70% | 25.50% | -38.20 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.07% | 2.97% | -4.04 | JNJ | /fcf-yield <GO> |
| Operating Margin | -20.00% | 34.70% | -54.70 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -33.00% | 28.50% | -61.50 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 0.50% | 6.00% | -5.50 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.76 | 5.59 | -0.83 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 8/9 | -5.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.6 | 62.1 | +3.53 | CTKB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $818.9M | $662.49B | -$661.67B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CTKB REV | JNJ REV | CTKB GROSS % | JNJ GROSS % | CTKB FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $201.5M | $94.19B | 51.8% | 67.9% | -$8.8M | $19.70B |
| FY 2024 | $200.5M | $88.82B | 55.4% | 69.1% | $21.9M | $19.84B |
| FY 2023 | $193.0M | $85.16B | — | — | $5.3M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CTKB // BETA —
JNJ // BETA 1.08